SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?


To: Jibacoa who wrote (94)10/29/2002 10:11:28 AM
From: Jibacoa  Respond to of 3722
 
EXEL Is up 53.63% with volume about 3x its daily average after the news yesterday evening of their deal with Glaxo.

The companies said: "they have allied to discover and commercialize novel therapeutics in the areas of vascular biology, inflammatory disease and cancer".

Glaxo is also going to acquire a small stake in EXEL.<g>

EXEL had been selling around 0.98 of book and there have been some insider and institutional buying. The reported cash/share is $3.00

biz.yahoo.com

Today's up-gap is a little too wide for my liking.<g>

siliconinvestor.com

I think I will wait to see if it can come down below the $4.20 level

siliconinvestor.com

Bernard